Somatropin hgh up until the mid 1980's came from the pituitary glands of cadavers obtained mostly from patients after death, since then the medical field regarding hgh has evolved exponentially since Eli Lilly & Company's Bio Synthetic version Humatrope was FDA APPROVED in 1987 which is the exact DNA match to the human body of 191 amino acids. In my opinion Humatrope has been the "GOLD STANDARD" OF Injectable HGH ever since.
A few notable pharmaceutical company's have since manufactured and have FDA Aproved products now as well so that said I must say this there are a couple close products to the Eli Lilly's Humatrope. Novo Nordisks Norditropin, Pfizers Genotropin and EMD Merck Serono all very high quality as well.
Somatropin hgh since then only recombinant form (bio-synthetic). freeze dried Somatropin HGH Human growth hormone, generic names - Somatotropin, Somatropin, Somatotrophin and to be clear right from the start "REAL" somatropin hgh is only available in a bio-synthetic injectable form. Not a product on the market even comes close to what benefits injectable hgh will be attained through a rigorous thrapy treatment.
So "DONT GET RIPPED OFF BY FALSE CLAIMS" of other products stating they provide the same or better results unless it is in injectable form from a legitimate pharmaceutical source. If the price is to good to be true....well i can say from experience that this is probably just that. Fake counterfeit products. Many come from China and are relabelled and packaged. You can go to the FDA Website and confirm this.
Somatropin HGH guru Keith Kelley, M.D., in 1985 a research scientist demonstrated that injections of cells that secrete high amounts of somatropin hgh human growth hormone could cause the shriveled thymus glands in old rats to grow until they became as large and healthy as those of young rats.
The thymus gland is the primary organ of the immune system. Immune system enhancement as a result of an increased level of somatropin hgh include the following: increased maturation of neutrophils; higher activity of natural killer cells; stimulation of macrophages;. increased production of red blood cells; the manufacture of new antibodies; increased production of T-cells and interleukin 2; and the greater proliferation and activity of lymphocyte cells.
Somatropin HGH is a protein molecule consisting of 191 amino acids which was discovered through medical schience that emerged in the 1980's, enabling researchers to splice human genes. The process of gene splicing enabled researchers to clone somatropin hgh human growth hormone proteins after identifying its exact sequence of DNA.
After the growth hormone protein was identical to that of the human DNA. it was then produced in drug laboratories in commercial quantities. Consequentially, biosynthetic somatropin (hgh) began to be available to medical researchers for the first time in the mid 1980's. This genetically engineered recombinant somatropin growth hormone is completely identical to the somatropin/IGF-1 naturally produced by the human pituitary gland and is therefore referred to as a natural hormone.
In the mid 1980's cadaver somatropin was pulled off the market after it was found to cause a rare disease called Creutzfe human growth hormone guru Dr. Daniel Rudman, an endocrinologist and medical researcher from Madison, Wisconsin, conducted the original and and most remarkable research of all time on the effect of somatropin hgh hormone replacement therapy in humans. By the time Dr. Rudman began his work in the mid-1980's, the safety of growth hormone had already been well established through its use in children with somatropin hgh deficiency. Dr.Rudman believed that changes in body composition which become apparent around age 35 had to do with declining hormone levels. The only method of testing his hypothesis was to replace somatropin hgh human growth hormone in deficient elderly adults to ascertain if the somatropin human growth hormone replacement reversed many of the effects associated with aging.
Somatropin hgh reversed the changes in body composition (ratios of body fat and lean body mass to total body weight) associated with aging, then somatropin hgh might reverse the loss of bodily structure and function that occurs with aging. To test his theory, Dr. Rudman began a study by replacing Somatropin HGH Human Growth Hormone in a group of older men to examine its effects on lean body mass and body fat in elderly adults. Dr. Rudman studied 26 men between the ages of 61 and 80 who had experienced significant adverse changes in body composition with age, but who were otherwise healthy. These men were overweight and had significantly low levels of Somatropin HGH.
Dr. Rudman selected hgh as the initial hormone to be replaced for two reasons. First, he was aware that the decline in somatropin hgh human growth hormone after age 35 was generally accompanied by an increase in body fat and a decline in lean muscle mass. Secondly, medical researchers in Sweden and Denmark had already determined that patients who were deficient in somatropin hghdue to pituitary dysfunction and had received Somatropin hgh replacement therapy became leaner without altering their lifestyles, diets or exercise programs, the men in Rudman's who received somatropin hgh human growth hormone replacement gained an average of 9% in lean muscle mass while losing 14% of body fat during their six month test. Bone density increased and their skin became thicker and firmer.
According to Rudman, the men who received somatropin hgh human growth hormone replacement therapy during the six months study experienced a reversal of the effects of aging by an astounding 10 to 20 years. Dr. Rudman concluded "The overall deterioration of the body that comes with growing old is not inevitable." Rudman's study, published in The New England Journal of Medicine in 1990, constituted a tremendous scientific breakthrough in the field of rejuvenation medicine.
The magnitude and the far reaching impact of Rudman's published study has yet to be determined. For the first time, medical science, empowered with the recently developed genetically engineered recombinant somatropin hgh had discovered a means for reversing the effects of aging in humans and as Dr Rudman had stated prolong the aging of the elders.
The course of the future and history for mankind was forever altered. Dr. Rudman inspired research scientists and physicians worldwide to investigate and research the use of somatropin hgh human growth hormone replacement therapy to reverse the effects of aging and treat diseases associated with aging. Concurrent with the time of Dr. Rudman's study, medical researchers in England, Sweden and Denmark were also discovering with consistency the remarkable effects of somatropin hgh human growth hormone replacement therapy on the results on preventing aging and even reversing aging.
Providing patients with somatropin hgh human growth hormone deficiencies arising from pituitary disease with somatropin hgh human growth hormone replacement had a remarkable impact upon such patients.
These patients had been depressed, experiencing low vitality, fatigue, anxiety, loss of sex drive and were dying prematurely at twice the average rate due to cardiovascular disease and other problems prior to use of somatropin hgh human growth hormone.
Somatropin hgh human growth hormone replacement therapy brought the patients out of their depression and fatigue into higher quality, productive and happy lives. In 1996, the New England Journal of Medicine, reported somatropin hgh human growth hormone replacement had reversed heart failure.
Today the National Institute On Aging is conducting six clinical trials in a multimillion dollar study of somatropin hgh human growth hormone replacement therapy to further confirm that human growth hormone prevents and in some cases they say reverses aging.
These are significant milestones being achieved. In August 1996, the Food and Drug Administration approved the use of somatropin hgh human growth hormone in adults with growth hormone deficiency due to low secretion of gh via the pituitary as well for a condition called hypothalamic disease.
Since the studies conducted in England, Sweden and Denmark since 1985 clearly demonstrate that aging is a pituitary disease, the recent FDA approval of adult Somatropin hgh replacement therapy now allows physicians in the United States to prescribe somatropin hgh for adults with low levels of IGF-1 for hormone defiency but many physicians have been known to prescribe it for off label uses for anti aging.
This possibly could come down to a legal matter with physicians in a fight with FDA Officials.
The FDA approved adult hormone (hgh) replacement therapy for adults with somatropin hgh deficiency syndrome after reviewing clinical data submitted to them by Eli Lilly and Company.
Eli Lilly secured FDA approval for adult somatropin hgh hormone replacement therapy because data collected and secured from Lilly's clinical trials significantly demonstrated that somatropin hgh replacement therapy resulted in many attributes that would lead to a better youthful lifestyle. the studies showed increased lean muscle mass, a significant decrease in body fat, an increase in exercise capacity, Increased energy levels, organ rejuvenation, hair regrowth, increased brain memory, tighter and younger looking skin, increased vitality and much more which helped these patients lead a much more fulfilled quality of life.
To Sum all these discrepencies between the FDA, top noted physicians and law makers, in my personal opinion one would have to lean towards the favor of Dr. Daniel Rudman who by far conducted the most indepth studies and trials for Somatropin HGH. He believed so strongly in the benefits of Somatropin HGH that he quoted before he passed on in the New England Journal of Medicine that patients should start taking growth hormone in their early 30's to prevent aging and the diseases related to aging instead of taking it whena person is in their 50 or 60's to reverse the aging process. Again a bold statement considering the long term effects of growth hormone were undetermined at that time.
So here we are some 25